Author
Akihiro Ohba
Also Known As
A. Ohba, Akihiro OHBA, Akihiro Ohba
103
Publications
1.1K
Citations
15
H-Index
41
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 9 | 9 | 290 |
2 | Engineering | 2 | 2 | 49 |
3 | Health Sciences | 1 | 1 | 103 |
4 | Natural Sciences | 1 | 1 | 28 |
5 | Biochemistry | 1 | 1 | 28 |
Akihiro Ohba
×
24
Publications
853
Citations
14
H-Index
| Year | Citations | |
|---|---|---|
2023 | 153 | |
2022 | 103 | |
2022 | 74 | |
2022 | 63 | |
2021 | 56 | |
1616O Nab-paclitaxel plus gemcitabine versus modified FOLFIRINOX or S-IROX in metastatic or recurrent pancreatic cancer (JCOG1611, GENERATE): A multicentred, randomized, open-label, three-arm, phase II/III trial Akihiro Ohba, Masato Ozaka, Gakuto Ogawa, Pancreatic CancerGastrointestinal OncologyMedicinePharmacologyCancer Treatment | 2023 | 51 |
2024 | 40 | |
2020 | 38 | |
2022 | 37 | |
2022 | 29 |
Page 1
Page 1